ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Levobupivacaine: International drug information (concise)

Levobupivacaine: International drug information (concise)
For abbreviations, symbols, and age group definitions used in Lexicomp (show table)
International Brand Names
International Brand Names by Country
For country code abbreviations (show table)

  • (AU) Australia: Chirocaine;
  • (BE) Belgium: Chirocaine | Levobupivacaine Fresenius Kabi;
  • (DE) Germany: Chirocaine;
  • (EG) Egypt: Chirocaine;
  • (ES) Spain: Levobupivacaina g.e.s | Levobupivacaina normon;
  • (FI) Finland: Chirocaine;
  • (FR) France: Chirocaine | Levobupivacaine altan | Levobupivacaine kabi;
  • (GB) United Kingdom: Levobupivacain;
  • (IE) Ireland: Chirocaine | Levobupivacain;
  • (IT) Italy: Chirocaine | Levobupivacaina altan | Levobupivacaina bioindustria;
  • (JP) Japan: Popscaine;
  • (KW) Kuwait: Chirocaine;
  • (LB) Lebanon: Chirocaine;
  • (NL) Netherlands: Chirocaine | Levobupivacaine Fresenius Kabi;
  • (PT) Portugal: Chirocaine;
  • (QA) Qatar: Chirocaine;
  • (SE) Sweden: Chirocaine;
  • (SI) Slovenia: Chirocaine;
  • (TR) Turkey: Chirocaine
Index Terms
  • (-)-bupivacaine;
  • (S)-bupivacaine;
  • L(-)-Bupivacaine;
  • Levobupivacaine Hydrochloride
Pharmacologic Category
  • Local Anesthetic
Reported Use

Epidural pain management; surgical anesthesia

Dosage Range

Note: Dose ranges are not intended to guide prescribing; consult local prescribing information for additional dosage and administration information.

Children >6 months to <12 years: Surgical anesthesia: Local infiltration (Ilioinguinal/iliohypogastric block): 0.5 mL/kg/side of 0.25% solution (maximum: 1.25 mg/kg/side) or 0.25 mL/kg/side of 0.5% solution (maximum: 1.25 mg/kg/side).

Adults:

Surgical anesthesia:

Dental: 5 to 10 mL of 0.5% to 0.75% solution.

Epidural:

Cesarean section: 15 to 30 mL of 0.5% solution; maximum single dose: 150 mg.

Surgery, not cesarean section: 10 to 20 mL of 0.5% to 0.75% solution; maximum single dose: 150 mg; prolonged surgeries may require a maximum cumulative dose of 400 mg/24 hours.

Intrathecal: 3 mL of 0.5% solution.

Local infiltration: 1 to 60 mL of 0.25% solution; maximum: 150 mg.

Ophthalmic (peribulbar block): 5 to 15 mL of 0.75% solution.

Peripheral nerve: 1 to 40 mL of 0.25% solution or 1 to 30 mL of 0.5% solution; maximum: 150 mg.

Pain management:

Labor pain (epidural bolus): 6 to 20 mL of 0.25% solution.

Labor pain (epidural infusion): 10 to 15 mL/hour of 0.0625% solution or 4 to 10 mL/hour of 0.125% solution (maximum: 12.5 mg/hour; a maximum cumulative dose of 400 mg per 24 hours is recommended).

Peri- and postoperative pain (epidural infusion): 10 to 15 mL/hour of 0.0625% solution, or 10 to 15 mL/hour of 0.125% solution, or 5 to 7.5 mL/hour of 0.25% solution (maximum rate: 18.75 mg/hour; maximum cumulative dose: 400 mg/24 hours; however, postoperative doses up to 570 mg/24 hours have been well tolerated).

Product Availability

Product available in various countries; not currently available in the US

Dosage Forms

Solution, Infusion/Injection: 2.5 mg/mL, 5 mg/mL, 7.5 mg/mL (10 mL)

Solution, Infusion [premixed]: 0.625 mg/mL, 1.25 mg/mL (100 mL, 200 mL)

Topic 96003 Version 28.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟